Re­pub­li­cans re­buke Pelosi drug pric­ing bill

Unit­ed be­hind the phar­ma­ceu­ti­cal in­dus­try’s crit­i­cism of a wide-rang­ing drug pric­ing bill from House Speak­er Nan­cy Pelosi (D-CA), Re­pub­li­cans on the sub­com­mit­tee on health of the House Com­mit­tee on En­er­gy & Com­merce on Wednes­day crit­i­cized the bill at length and re­ferred to the ne­go­ti­a­tion pro­vi­sions as price con­trols.

Chair­woman An­na Es­hoo (D-CA), how­ev­er, coun­tered that the bill, known as HR 3, in­cludes many pro­vi­sions that Pres­i­dent Don­ald Trump and oth­er Re­pub­li­cans have al­ready sup­port­ed. She al­so ex­plained how Re­pub­li­cans pre­vi­ous­ly sup­port­ed al­low­ing the De­part­ment of Vet­er­ans Af­fairs to ne­go­ti­ate prices of pre­scrip­tion drugs, which has re­sult­ed in sig­nif­i­cant sav­ings.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER